Pharmabiz2h
Boston Pharma announces positive phase 2 data on efimosfermin alfa, a long-acting FGF21 analogue in patients with stage F2/F3 fibrosis due to MASH
Boston Pharmaceuticals, a clinical-stage biopharmaceutical company developing differentiated molecules addressing serious liver diseases, announced positive results from a phase 2 study evaluating the ...
Pharmabiz33m
Ayush Ministry to amend D&C Rules to regulate retail outlets of ASU drugs
The Union Ministry of Ayush (MOA) will soon amend rules to regulate the retail sale outlets of the Ayurveda, Siddha and Unani (ASU) drugs in order to ensure safety, efficacy and quality of these ...
Pharmabiz3h
US FDA accepts for review the resubmission of sBLA for Dupixent to treat chronic spontaneous urticaria
US FDA accepts for review the resubmission of sBLA for Dupixent to treat chronic spontaneous urticaria: Paris Monday, November 18, 2024, 11:00 Hrs [IST] The US Food and Drug Admin ...
Pharmabiz4h
iiCON funds 11 new innovative projects focused on tackling infectious diseases
After successful sandpit events in Liverpool and London earlier this year, iiCON (Infection Innovation Consortium) is excited to announce 11 new projects during World AMR Awareness Week. These ...
Pharmabiz5h
EMA committee recommends approval of Bristol Myers’ repotrectinib to treat advanced ROS1-positive NSCLC & NTRK-positive solid tumours
EMA committee recommends approval of Bristol Myers’ repotrectinib to treat advanced ROS1-positive NSCLC & NTRK-positive solid tumours: Princeton, New Jersey Monday, November 18, ...
Pharmabiz6h
Indian cancer centres adopting patient-reported outcomes to assess benefit-risk profile of therapies
Indian cancer centres adopting patient-reported outcomes to assess benefit-risk profile of therapies: Nandita Vijayasimha, Bengaluru Monday, November 18, 2024, 08:00 Hrs [IST] Ind ...
Pharmabiz6h
Nutraceuticals under drug regulation more beneficial; recommendations lack important aspects: Experts
Nutraceuticals under drug regulation more beneficial; recommendations lack important aspects: Experts: Gireesh Babu, New Delhi Monday, November 18, 2024, 08:00 Hrs [IST] Bringing ...
Pharmabiz6h
Pharmaceuticals exports report 8.21 per cent growth in October
Exports of drugs and pharmaceuticals from the country registered a growth of 8.21 per cent during the month of October this year, as compared to the same month of last year. Imports during the month ...
Pharmabiz2d
Dr. Nimmy VS of Vaidyaratnam Ayurveda College wins first prize in All India Ayurveda Thesis Competition 2024
Peethaambaran Kunnathoor, Chennai Saturday, November 16, 2024, 08:00 Hrs [IST] ...
Pharmabiz2d
New investment from the ADDF’s Diagnostics Accelerator leads efforts to develop standardization materials for leading diagnostic biomarker
New investment from the ADDF’s Diagnostics Accelerator leads efforts to develop standardization materials for leading diagnostic biomarker: New York Saturday, November 16, 2024, ...
Pharmabiz1d
icometrix’s AI-driven MRI solution, icobrain aria receives US FDA clearance for safer Alzheimer’s treatment
AI-driven MRI solution, icobrain aria receives US FDA clearance for safer Alzheimer’s treatment: Boston Saturday, November 16, 2024, 16:00 Hrs [IST] icometrix, a g ...
Pharmabiz1d
EMA committee recommends approval of Eisai & Biogen’s lecanemab to treat early Alzheimer’s disease
Eisai Co., Ltd. and Biogen Inc., a leading biotechnology company, announced a positive opinion has been received from the Committee for Medicinal Products for Human Use (CHMP) of the European ...